Understand the source comparison
Direct Mechanism Comparison
The fundamental misunderstanding about peptides for leaky gut compared centres on the difference between signalling molecules and building blocks. Intestinal hyperpermeability. The clinical term for 'leaky gut'. Occurs when tight junction proteins (occludin, c
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The fundamental misunderstanding about peptides for leaky gut compared centres on the difference between signalling molecules and building blocks. Intestinal hyperpermeability. The clinical term for 'leaky gut'. Occurs when tight junction proteins (occludin, claudin, zonulin) between enterocytes become compromised, allowing undigested food particles, bacterial endotoxins, and inflammatory mediators to cross into systemic circulation. This triggers immune activation, chronic inflammation, and the cascade of symptoms patients associate with the condition.
- BPC-157 (body protection compound-157) is a synthetic pentadecapeptide derived from gastric juice proteins. Its mechanism involves direct upregulation of growth factors. Specifically VEGF and fibroblast growth factor (FGF). That promote capillary formation and accelerate tissue repair in damaged intestinal mucosa. Research conducted at the University of Zagreb demonstrated that BPC-157 administration reduced inflammatory cytokine expression (TNF-alpha, IL-6) by 35–45% in colitis models while simultaneously increasing epithelial cell proliferation rates. The peptide doesn't just provide raw material. It actively signals the gut lining to repair itself.
- Thymosin beta-4 operates through a different pathway entirely. This 43-amino-acid peptide regulates actin, the structural protein that maintains cellular architecture. In the intestinal context, TB-4 stabilises the cytoskeletal framework that anchors tight junction proteins in place. Studies published in Gastroenterology found that TB-4 administration reduced intestinal permeability by 30–40% in inflammatory bowel disease models, primarily by preventing the degradation of existing tight junctions rather than accelerating new cell growth. The distinction matters: BPC-157 rebuilds damaged tissue, while TB-4 prevents further breakdown.
- Collagen peptides. Typically marketed as 'gut healing' supplements. Serve an entirely different function. These are hydrolysed protein fragments (dipeptides and tripeptides) that provide glycine, proline, and hydroxyproline: the amino acids required for collagen synthesis throughout the body, including the basement membrane underlying intestinal epithelium. A 2022 study in Nutrients demonstrated that 10g daily collagen supplementation improved subjective digestive symptoms in 62% of participants, but lactulose/mannitol testing (the gold standard for measuring intestinal permeability) showed only modest improvement. 12–18% reduction in permeability ratios over 12 weeks. Collagen provides substrate; it doesn't trigger repair signalling.